IP Library › Granted Patent US 12,521,082
Granted Patent B2
US 12,521,082 · App. 17/419,845 · Granted Jan 13, 2026

Additive manufacturing of radiological phantoms

Inventors: Daniel Dikovsky (Ariel, IL); Diana Ravich (Natania, IL); Avraham Levy (Petach-Tikva, IL); Ben Klein (Tel-Aviv, IL)
Assignee: Stratasys Ltd.
A61B6/583B29C64/112B33Y10/00B33Y70/00B29K2995/0018
View Patent ↗
Loading inventors, assignments & file history…
Monitor This Case
Get email alerts when status or documents change.
Order Certified Copies
Most orders are placed with the USPTO same day — all within 24 business hours.
Order via The Patent Place →
Pre-filled with this patent's details
Quick Facts
Patent No.
US 12,521,082
App. No.
17/419,845
Granted
Jan 13, 2026
Kind
B2
Abstract

A formulation usable as a modeling material formulation in additive manufacturing of a three-dimensional object and additive manufacturing methods utilizing same are provided. The formulation comprises one or more curable materials; and a radiopaque material, and features, when hardened, a CT number of at least 100 HU at 70 kV. Objects made by the additive manufacturing method utilizing the formulation are usable as radiological phantoms.

Claims (24)

1 . A modeling material formulation usable in additive manufacturing of a three-dimensional object, the formulation comprising:

one or more curable materials which are photopolymerizable materials that polymerize and/or undergo cross-linking upon exposure to radiation; and

a radiopaque material in an amount that ranges from 5 to 50%, by weight of the total weight of the formulation,

wherein said radiopaque material is a curable material which is a photopolymerizable material that polymerizes and/or undergoes cross-linking upon exposure to radiation and which contains one or more photocurable groups and one or more radiopaque elements or one or more groups containing a radiopaque element, wherein said radiopaque element is bromine,

and wherein said one or more curable materials comprise one or more monofunctional curable material(s) featuring, when hardened, Tg lower than 20° C. and/or one or more multifunctional curable material(s) featuring, when hardened, Tg lower than 20° C.,

the formulation featuring, when hardened, a CT number of at least 100 HU at 70 kV.

2 . The formulation of claim 1 , featuring, when hardened, a CT number of at least 500 HU at 70 kV.

3 . The formulation of claim 1 , wherein the three-dimensional object is a radiological phantom.

4 . The formulation of claim 1 , wherein the additive manufacturing is 3D inkjet printing.

5 . The formulation of claim 1 , featuring a viscosity of from 8 to about 50, centipoises at 75° C.

6 . The formulation of claim 1 , wherein an amount of said radiopaque material ranges from 5 to 30%, by weight of the total weight of the formulation.

7 . The formulation of claim 1 , wherein said curable materials are UV-curable materials which polymerize and/or undergo cross-linking upon exposure to UV irradiation.

8 . The formulation of claim 7 , further comprising a photoinitiator.

9 . The formulation of claim 8 , wherein an amount of said photoinitiator ranges from 2 to 6%, by weight of total weight of the formulation.

10 . The formulation of claim 1 , wherein said one or more curable materials comprise one or more monofunctional curable material(s) featuring, when hardened, Tg higher than 50° C.

11 . The formulation of claim 10 , wherein a total amount of said one or more monofunctional curable material(s) that features, when hardened, Tg higher than 50° C. ranges from 20% to 40%, by weight of total weight of the formulation.

12 . The formulation of claim 1 , wherein a total amount of said one or more monofunctional curable material(s) featuring, when hardened, Tg lower than 20° C. ranges from 5 to 15, % by weight of the total weight of the formulation.

13 . The formulation of claim 1 , wherein said one or more curable materials comprise one or more multifunctional curable material(s) featuring, when hardened, Tg higher than 50° C.

14 . The formulation of claim 13 , wherein a total amount of said one or more multifunctional curable material(s) featuring, when hardened, Tg higher than 50° C. ranges from 5% to 15%, by weight of total weight of the formulation.

15 . The formulation of claim 1 , wherein a total amount of said one or more multifunctional curable material(s) featuring, when hardened, Tg lower than 20° C. ranges from 15 to 25, % by weight of the total weight of the formulation.

16 . A method of additive manufacturing a three-dimensional object, the method comprising dispensing at least one modeling material formulation to sequentially form a plurality of layers in a configured pattern corresponding to a shape of the object, wherein for at least a portion of said layers, said at least one modeling material formulation is the formulation of claim 1 .

17 . The method of claim 16 , wherein said dispensing is via one or more 3D inkjet printing arrays.

18 . The method of claim 16 , further comprising exposing at least a portion of the dispensed layers to a curing condition to thereby obtain a hardened formulation featuring said CT number, said curing condition comprising irradiation.

19 . A three-dimensional object comprising, in at least a portion thereof, a hardened material that features a CT number of at least 100 HU at 70 kV, obtained by the method of claim 16 .

Assignments (1)
ASSIGNMENT OF ASSIGNOR'S INTEREST Recorded Aug 16, 2021
From: DIKOVSKY, DANIEL; RAVICH, DIANA; LEVY, AVRAHAM; KLEIN, BEN
To: STRATASYS LTD.
Reel/Frame 057181/0371 →
Continuity (2)
Provisional Application 62786793 · Dec 31, 2018
Related Publication 20220079547A1 · Mar 17, 2022
References Cited (67)
US 6259962B1 · Gothait · 2001 [cited by applicant]
US 6569373B2 · Napadensky · 2003 [cited by applicant]
US 6658314B1 · Gothait · 2003 [cited by applicant]
US 6850334B1 · Gothait · 2005 [cited by applicant]
US 7183335B2 · Napadensky · 2007 [cited by applicant]
US 7209797B2 · Kritchman et al. · 2007 [cited by applicant]
US 7225045B2 · Gothait · 2007 [cited by applicant]
US 7300619B2 · Napadensky et al. · 2007 [cited by applicant]
US 7479510B2 · Napadensky et al. · 2009 [cited by applicant]
US 7500846B2 · Eshed et al. · 2009 [cited by applicant]
US 7962237B2 · Kritchman · 2011 [cited by applicant]
US 9031680B2 · Napadensky · 2015 [cited by applicant]
US 9227365B2 · Dikovsky et al. · 2016 [cited by applicant]
US 9364986B1 · Patterson · 2016 [cited by examiner]
US 20030207959A1 · Napadensky et al. · 2003 [cited by applicant]
US 20060036316A1 · Zeltinger · 2006 [cited by examiner]
US 20100191360A1 · Napadensky · 2010 [cited by applicant]
US 20160113846A1 · Willner · 2016 [cited by applicant]
US 20160256711A1 · Pappas · 2016 [cited by examiner]
US 20170224591A1 · Vogel · 2017 [cited by examiner]
US 20180104946A1 · Bentz et al. · 2018 [cited by applicant]
US 20200354542A1 · O'Sullivan · 2020 [cited by examiner]
CN 101256849 · 2008 [cited by applicant]
CN 105101935 · 2015 [cited by applicant]
CN 106061554 · 2016 [cited by applicant]
CN 106659640 · 2017 [cited by applicant]
CN 108367494 · 2018 [cited by applicant]
EP 2990061A1 · 2016 [cited by examiner]
EP 2990061 · 2016 [cited by applicant]
JP 2005111988 · 2005 [cited by applicant]
JP 2014531503 · 2014 [cited by applicant]
JP 201543793 · 2015 [cited by applicant]
JP 2016536085 · 2016 [cited by applicant]
JP 2016536434 · 2016 [cited by applicant]
WO WO2016103973 · 2016 [cited by applicant]
WO WO2016142947 · 2016 [cited by applicant]
WO WO2017029657 · 2017 [cited by applicant]
WO WO2017122211 · 2017 [cited by applicant]
WO WO2018222779 · 2018 [cited by applicant]
WO WO2019021291 · 2019 [cited by applicant]
WO WO2019021292 · 2019 [cited by applicant]
WO WO2019021293 · 2019 [cited by applicant]
WO WO2019021294 · 2019 [cited by applicant]
WO WO2019021295 · 2019 [cited by applicant]
WO WO2019211420 · 2019 [cited by applicant]
WO WO2020141519 · 2020 [cited by applicant]
WO WO2020141519A8 · 2020 [cited by applicant]
Artola et al: “Elimination of barium sulphate from acrylic bone cements. Use of two iodine-containing monomers”, Biomaterials, Elsevier, Amsterdam, NL, vol. 24, No. 22, Oct. 1, 2003, pp. 4071-4080 (Year: 2003). [cited by examiner]
Davy et al.: X-Ray opaque methacrylate polymers for biomedical applications; Polymer International 43 (1997) pp. 143-154 (Year: 1997). [cited by examiner]
Communication Pursuant to Article 94(3) EPC Dated Sep. 5, 2023 From the European Patent Office Re. Application No. 19839160.9. (6 Pages). [cited by applicant]
Notice of Reason(s) for Rejection Dated Sep. 12, 2023 From the Japan Patent Office Re. Application No. 2021-538300. (3 pages). [cited by applicant]
International Preliminary Report on Patentability Dated Jul. 15, 2021 From the International Bureau of WIPO Re. Application No. PCT/IL2019/051439. (8 Pages). [cited by applicant]
International Search Report and the Written Opinion Dated Apr. 24, 2020 From the International Searching Authority Re. Application No. PCT/IL2019/051439. (11 Pages). [cited by applicant]
Artola et al. “Elimination of Barim Sulphate From Acrylic Bone Cements. Use of Two Iodine-Containing Monomers”, Biomaterials, XP004434250, 24(22): 4071-4080, Oct. 2003. [cited by applicant]
Badal et al. “Reproducing Two-Dimensional Mammograms With Three-Dimensional Printed Phantoms”, Journal of Medical Imaging, 5(3): 033501-1-0533501-10, Published Online Jul. 12, 2018. [cited by applicant]
FitzGerald et al. “CT Image Contrast of High-Z Elements: Phantom Imaging Studies and Clinical Implications”, Radiology, 278(3): 723-733, Published Online Sep. 10, 2015. [cited by applicant]
Gear et al. “Abdo-Man: A 3D-Printed Anthropomorphic Phantom for Validating Quantitative SIRT”, EJNMMI Physics, 3(1): 17-1-17-16, Published Online Aug. 5, 2016. [cited by applicant]
Mitsouras et al. “Medical 3D Printing for Radiologist”, RadioGraphics, 35(7):1965-1988, Published Online Nov. 12, 2015. & Appendix. [cited by applicant]
Mitsouras et al. “Three-Dimensional Printing of MRI-Visible Phantoms and MR Image-Guided Therapy Simulation”, Magnetic Resonance in Medicine, 77(2): 613-622, Published Online Feb. 11, 2016. & Supporting Table. [cited by applicant]
Translation Dated Oct. 4, 2023 of Notice of Reason(s) for Rejection Dated Sep. 12, 2023 From the Japan Patent Office Re. Application No. 2021-538300. (6 pages). [cited by applicant]
English Summary Dated Dec. 25, 2023 of Notification of Office Action and Search Report Dated Dec. 12, 2023 From the State Intellectual Property Office of the People's Republic of China Re. Application No. 201980090051.9… [cited by applicant]
Notification of Office Action and Search Report Dated Dec. 12, 2023 From the State Intellectual Property Office of the People's Republic of China Re. Application No. 201980090051.9 and Its Machine Translation Into Engli… [cited by applicant]
Notice of Reason(s) for Rejection Dated Feb. 13, 2023 From the Japan Patent Office Re. Application No. 2021-538300. (3 pages). [cited by applicant]
Translation Dated Feb. 28, 2024 of Notice of Reason(s) for Rejection Dated Feb. 13, 2023 From the Japan Patent Office Re. Application No. 2021-538300. (6 pages). [cited by applicant]
Decision on Rejection Dated Jul. 27, 2024 From the State Intellectual Property Office of the People's Republic of China Re. Application No. 201980090051.9. and Its Machine Translation Into English. (13 Pages). [cited by applicant]
English Summary Dated Aug. 6, 2024 of Decision on Rejection Dated Jul. 27, 2024 From the State Intellectual Property Office of the People's Republic of China Re. Application No. 201980090051.9. (2 Pages). [cited by applicant]
Office Action Dated Jun. 13, 2024 From the Israel Patent Office Re. Application No. 284522. (4 Pages). [cited by applicant]